All Stories

  1. Cancer drug sacituzumab govitecan can stop tumour cells dividing in lab tests

    Article • Molecular Pharmacology, September 2026, Elsevier

    David Gewirtz, David Sommer

  2. Is autophagy induction by PARP inhibitors a target for therapeutic benefit?

    Article • Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, January 2022, Tsinghua University Press

    David Gewirtz

  3. Young plasma attenuates age-dependent liver ischemia reperfusion injury

    Article • The FASEB Journal, February 2019, Federation of American Societies For Experimental Biology (FASEB)

    Anding Liu, Uta Dahmen, David Gewirtz